You just read:

Amgen Announces Positive Top-Line Results From Phase 3 LAPLACE-2 Trial Of Evolocumab (AMG 145) In Combination With Statins In Patients With High Cholesterol

News provided by

Amgen

Jan 28, 2014, 04:03 EST